NFKB1 and Miyoshi myopathy: Raninga et al. reported that hypoxia induces NF-κB signaling by elevating TrxR1 protein levels in bortezomib-resistant MM cells, whereas knockdown of TrxR1 and redox protein thioredoxin 1 (Trx1) reverses drug resistance [217, 218].